Lewis J C, O'Flaherty J T, McCall C E, Wykle R L, Bond M G
Exp Mol Pathol. 1983 Feb;38(1):100-8. doi: 10.1016/0014-4800(83)90102-8.
Morphometric analysis of endothelium in rabbit lungs demonstrated a dramatic effect of platelet-activating factor (PAF) on the ultrastructure of pulmonary vasculature. Plasmalemmal vesicles in capillaries were increased both in size (638 A PAF vs 538 A control) and in number (386/micrograms 3 cytoplasm PAF vs 125/micrograms 3 cytoplasm control) when PAF was administered as a single acute low dose (chi less than 3 micrograms/kg). High concentrations of PAF (chi greater than 3 micrograms/kg) as a single acute dose also increased vesicle number (203/micrograms 3 cytoplasm), but frequently precipitated the respiratory distress syndrome. Chronic administration of PAF with daily doses over periods of either 3.5 or 7 weeks resulted in changes paralleling the acute observations, but did not lead to more extensive lung disease.
对兔肺内皮进行形态计量学分析显示,血小板活化因子(PAF)对肺血管超微结构有显著影响。当以单次急性低剂量(小于3微克/千克)给予PAF时,毛细血管中的质膜小泡大小(PAF组为638埃,对照组为538埃)和数量(PAF组每微克3细胞质中有386个,对照组每微克3细胞质中有125个)均增加。高浓度的PAF(大于3微克/千克)作为单次急性剂量也增加了小泡数量(每微克3细胞质中有203个),但常引发呼吸窘迫综合征。以每日剂量连续3.5周或7周慢性给予PAF,导致的变化与急性观察结果相似,但未导致更广泛的肺部疾病。